Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Square Pharmaceuticals is the largest pharmaceutical company in Bangladesh and a significant player in the global generic drug market. The company manufactures and markets a wide array of products, including small molecule generics and an expanding portfolio of biosimilars such as trastuzumab and rituximab. With state-of-the-art manufacturing facilities that meet international regulatory standards (US FDA, UK MHRA), Square exports to over 40 countries across Asia, Africa, and Europe. The company is publicly traded on the Dhaka Stock Exchange and continues to invest heavily in R&D and high-tech manufacturing to maintain its leadership position in the regional and international pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Squire Pharmaceuticals.